However, further research, including euglycemic insulin clamp and PET studies, are warranted to entirely unveil the mechanisms underlying the higher insulin sensitivity and the lower prevalence of T2D in SSc patients. This evidence concerns the gene INS and type 2 diabetes mellitus.